Author:
Pope Jason E.,Antony Ajay,Petersen Erika A.,Rosen Steven M.,Sayed Dawood,Hunter Corey W.,Goree Johnathan H.,Vu Chau M.,Bhandal Harjot S.,Shumsky Philip M.,Bromberg Todd A.,Smith G. Lawson,Lam Christopher M.,Kalia Hemant,Lee Jennifer M.,Khurram Abeer,Gould Ian,Karantonis Dean M.,Deer Timothy R.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Shanthanna H, Eldabe S, Provenzano DA, Bouche B, Buchser E, Chadwick R, et al. Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain. Reg Anesth Pain Med. 2023;48(6):273–87.
2. Food and Drug Administration. Medtronic, Inc.; Premarket approval of the Medtronic Itrel spinal cord stimulation system. 1984.
3. FDA. Conduct a trial stimulation period before implanting a spinal cord stimulator (SCS)—letter to health care providers [Internet]. FDA. 2020 [cited 2023 Jan 3]. Available from: https://www.fda.gov/medical-devices/letters-health-care-providers/conduct-trial-stimulation-period-implanting-spinal-cord-stimulator-scs-letter-health-care-providers
4. Thomson SJ, Tavakkolizadeh M, Love-Jones S, Patel NK, Gu JW, Bains A, et al. Effects of rate on analgesia in kilohertz frequency spinal cord stimulation: results of the PROCO randomized controlled trial. Neuromodul Technol Neural Interface 2018;21(1):67–76.
5. Metzger CS, Hammond MB, Paz-Solis JF, Newton WJ, Thomson SJ, Pei Y, et al. A novel fast-acting sub-perception spinal cord stimulation therapy enables rapid onset of analgesia in patients with chronic pain. Expert Rev Med Devices. 2021;18(3):299–306.